FDFT1 Antikörper (AA 367-417)
Kurzübersicht für FDFT1 Antikörper (AA 367-417) (ABIN7450244)
Target
Alle FDFT1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 367-417
-
Verwendungszweck
- Rabbit anti-FDFT1 Antibody, Affinity Purified
-
Homologie
- Bovine,Orangutan
-
Aufreinigung
- Affinity Purified
-
Immunogen
- Between AA 367 and 417
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
IP: 2 - 10 μg/mg lysate
WB: 1:2,000 - 1:10,000
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 1000 μg/mL
-
Buffer
- Tris-citrate/phosphate buffer, pH 7 to 8 containing 0.09 % Sodium Azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C
-
Haltbarkeit
- 12 months
-
-
- FDFT1 (Farnesyl-Diphosphate Farnesyltransferase 1 (FDFT1))
-
Andere Bezeichnung
- FDFT1
-
Hintergrund
- Background: Farnesyl-diphosphate farnesyltransferase 1 (FDFT1) is a membrane-associated enzyme located at a branch point in the mevalonate pathway. FDFT1 is the first specific enzyme in cholesterol biosynthesis, catalyzing the dimerization of two molecules of farnesyl diphosphate in a two-step reaction to form squalene [taken from NCBI Entrez Gene (Gene ID: 2222)].
-
Gen-ID
- 2222
-
UniProt
- P37268
-
Pathways
- Regulation of Lipid Metabolism by PPARalpha
Target
-